Jones Financial Companies
MESO

Jones Financial Companies’s Mesoblast MESO Stock Holding History

Jones Financial Companies’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.31K Hold
300
– – ﹤0.01% 3896
2025
Q4 		$5.41K Hold
300
– – ﹤0.01% 3464
2025
Q3 		$4.76K Hold
300
– – ﹤0.01% 3372
2025
Q2 		$3.28K Buy
+300
New +$3.36K ﹤0.01% 3294

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jones Financial Companies's MESO Position: Q1 2026 in Review

Jones Financial Companies held its Mesoblast (MESO) position steady in Q1 2026 at 300 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #3896.

Jones Financial Companies first reported a position in MESO in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.41K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Jones Financial Companies held 300 shares of Mesoblast worth $4.31K as of Q1 2026.
  • Jones Financial Companies left its Mesoblast share count unchanged in Q1 2026.
  • Mesoblast made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3896 holding.
  • Jones Financial Companies first reported a position in Mesoblast in Q2 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's Mesoblast position peaked at $5.41K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.